Survival rates for childhood leukemia are improving thanks to new treatments. Acute lymphoblastic leukemia has the highest survival among all pediatric cancers, 80-85 percent. Seattle Children’s ...

Elias Jabbour, MD, is a board-certified hematologist-oncologist and internationally recognized leukemia specialist. He is a Professor of Medicine and Chief of the Acute Lymphoblastic Leukemia (ALL) ...

Hematologist-oncologists are doctors who specialize in treating blood cancers such as acute lymphoblastic leukemia (ALL). ALL is a rare, rapidly progressing cancer of the blood and bone marrow. The ...

In the first clinical trial of dose-adjusted EPOCH along with inotuzumab ozogamicin (InO) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), Fred Hutch Cancer Center ...

Among the efficacy evaluable patients, 42% achieved complete remission within 3 months. The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the ...

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the commonest cancer in childhood and one that can be ...

In patients with Philadelphia chromosome (Ph)-positive B-cell acute lymphoblastic leukemia who experience relapse after consolidation with allogeneic hematopoietic cell transplantation (HCT), ...

Acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) are types of blood cancer. Acute lymphoblastic leukemia is a fast-growing type of blood cancer. It happens when the body makes too ...

Highlights in acute lymphoblastic leukemia (ALL), presented at the American Society of Hematology (ASH) 2024 Annual Meeting and Exposition, include studies on pediatric and adult disease, as discussed ...